An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for ...
ATLANTA — Michael is finally turning a corner. Four days after major lung surgery, the brave 12-year-old is breathing easier.
A doctor whose research into a rare type of brain tumour has led to better outcomes for babies diagnosed with the condition says it is a "massive step forward" in cancer treatment.
During the first three years of Augenstein’s lung cancer journey, he’s been happy to be able to share things he has been learning along the way.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
What is the difference between targeted therapy and immunotherapy in cancer Read ahead to know as an expert breaks down how ...
Mum-of-four and influencer Hayley Berlingeri, who was diagnosed with an inoperable tumour last year, has taken to social ...
About two weeks ago, Jason Myrtetus received a phone call from the Flyers. The team was figuring out its plans for the annual ...
After her shocking lung cancer diagnosis, the late Susan Wojcicki dedicated herself to fighting the disease and looking for ...
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous NSCLC ...
Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback